Skip to main content

Advertisement

SpringerLink
Log in

Enzymes involved in the biosynthesis of leukotriene B4 and prostaglandin E2 are active in sebaceous glands

  • Original Article
  • Published:
Journal of Molecular Medicine Aims and scope Submit manuscript

Abstract

The expression of enzymes involved in leukotriene and prostaglandin signalling pathways, of interleukins 6 and 8 and of peroxisome proliferator-activated receptors in sebaceous glands of acne-involved facial skin was compared with those of non-involved skin of acne patients and of healthy individuals. Moreover, 5-lipoxygenase and leukotriene A4 hydrolase were expressed at mRNA and protein levels in vivo and in SZ95 sebocytes in vitro (leukotriene A4 hydrolase > 5-lipoxygenase), while 15-lipoxygenase-1 was only detected in cultured sebocytes. Cyclooxygenase-1 and cyclooxygenase-2 were also present. Peroxisome proliferator-activated receptors were constitutively expressed. Enhanced 5-lipoxygenase, cyclooxygenase 2 and interleukin 6 expression was detected in acne-involved facial skin. Arachidonic acid stimulated leukotriene B4 and interleukin 6 release as well as prostaglandin E2 biosynthesis in SZ95 sebocytes, induced abundant increase in neutral lipids and down-regulated peroxisome proliferator-activated receptor-α, but not receptor-γ1 mRNA levels, which were the predominant peroxisome proliferator-activated receptor isotypes in SZ95 sebocytes. In conclusion, human sebocytes possess the enzyme machinery for functional leukotriene and prostaglandin pathways. A comprehensive link between inflammation and sebaceous lipid synthesis is provided.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  1. Brown SK, Shalita AR (1998) Acne vulgaris. Lancet 351:1871–1876

    Article  PubMed  Google Scholar 

  2. Ingham E, Eady EA, Goodwin CE, Cove JH, Cunliffe WJ (1992) Pro-inflammatory levels of interleukin-1 alpha-like bioactivity are present in the majority of open comedones in acne vulgaris. J Invest Dermatol 98:895–901

    Article  PubMed  Google Scholar 

  3. Jeremy AH, Holland DB, Roberts SG, Thomson KF, Cunliffe WJ (2003) Inflammatory events are involved in acne lesion initiation. J Invest Dermatol 121:20–27

    Article  PubMed  Google Scholar 

  4. Zouboulis CC (2001) Is acne vulgaris a genuine inflammatory disease? Dermatology 203:277–279

    Article  PubMed  Google Scholar 

  5. Zouboulis CC, Eady A, Philpott M, Goldsmith LA, Orfanos CE, Cunliffe WC, Rosenfield R (2005) What is the pathogenesis of acne? Exp Dermatol 14:143–152

    Article  PubMed  Google Scholar 

  6. Zouboulis CC (2003) Leukotrien-Antagonisten bei atopischen Erkrankungen und Akne. Akt Dermatol 29:419–425

    Article  Google Scholar 

  7. Yokomizo T, Izumi T, Shimizu T (2001) Metabolism and signal transduction. Arch Biochem Biophys 355:231–241

    Article  Google Scholar 

  8. Samuelsson B (1983) Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science 220:568–575

    PubMed  Google Scholar 

  9. Ghosh J, Myers CE (1988) Inhibition of arachidonate 5-lipoxygenase triggers massive apoptosis in human prostate cancer cells. Proc Natl Acad Sci U S A 95:13182–13187

    Article  Google Scholar 

  10. Haeggstrom J Z (2004) Leukotriene A4 hydrolase/aminopeptidase, the gatekeeper of chemotactic LTB4 biosynthesis. J Biol Chem 279:50639–50642

    Article  PubMed  Google Scholar 

  11. Funk CD (2001) Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294:1871–1875

    Article  PubMed  Google Scholar 

  12. Haeggstrom JZ, Kull F, Rudberg PC, Tholander F, Thunissen MGM (2002) Leukotriene A4 hydrolase. Prostaglandins Other Lipid Mediat 68–69:495–510

    Article  PubMed  Google Scholar 

  13. Ziboh VA, Miller CC, Cho Y (2000) Significance of lipoxygenase-derived monohydroxy fatty acids in cutaneous biology. Prostaglandins Other Lipid Mediat 63:3–13

    Article  PubMed  Google Scholar 

  14. Serhan CN, Jain A, Marleau S, Clish C, Kantarci A, Behbehani B, Colgan SP, Stahl GL, Merched A, Petasis NA, Chan L, Van Dyke TE (2003) Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators. J Immunol 171:6856–6865

    PubMed  Google Scholar 

  15. Rosenfield RL, Deplewski D, Kentsis A, Ciletti N (1998) Mechanisms of androgen induction of sebocyte differentiation. Dermatology 196:43–46

    Article  PubMed  Google Scholar 

  16. Chen W, Yang C-C, Sheu H-M, Seltmann H, Zouboulis CC (2003) Expression of peroxisome proliferator-activated receptor and CCAAT/enhancer binding protein transcription factors in cultured human sebocytes. J Invest Dermatol 121:441–447

    Article  PubMed  Google Scholar 

  17. Delerive P, Fruchart JC, Staels B (2001) Peroxisome proliferator-activated receptors in inflammation control. J Endocrinol 169:453–459

    Article  PubMed  Google Scholar 

  18. Thuillier P, Brash AR, Kehrer JP, Stimmel JB, Leesnitzer LM, Yang P, Newman RA, Fischer SM (2002) Inhibition of peroxisome proliferator-activated receptor (PPAR)-mediated keratinocyte differentiation by lipoxygenase inhibitors. Biochem J 366:901–910

    PubMed  Google Scholar 

  19. Wróbel A, Seltmann H, Fimmel S, Müller-Decker K, Tsukada M, Bogdanoff B, Mandt N, Blume-Peytavi U, Orfanos CE, Zouboulis CC (2003) Differentiation and apoptosis in human immortalized sebocytes. J Invest Dermatol 120:175–181

    Article  PubMed  Google Scholar 

  20. Ferre P (2004) The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity. Diabetes 53(Suppl 1):S43–S50

    PubMed  Google Scholar 

  21. Neufang G, Furstenberger G, Heidt M, Marks F, Muller-Decker K (2001) Abnormal differentiation of epidermis in transgenic mice constitutively expressing cyclooxygenase-2 in skin. Proc Natl Acad Sci U S A 98:7629–7634

    Article  PubMed  Google Scholar 

  22. Zouboulis CC, Seltmann H, Neitzel H, Orfanos CE (1999) Establishment and characterization of an immortalized human sebaceous gland cell line (SZ95). J Invest Dermatol 113:1011–1020

    Article  PubMed  Google Scholar 

  23. Müller-Decker K, Reinerth G, Krieg P, Zimmermann R, Heise H, Bayerl C, Marks F, Fürstenberger G (1999) Prostaglandin-H-synthase isozyme expression in normal and neoplastic human skin. Int J Cancer 82:648–656

    Article  PubMed  Google Scholar 

  24. Ponton A, Thirion JP, Sirois P (1997) Repression of the 5-lipoxygenase gene by c-myb overexpression in differentiated HL-60 cells. Prostaglandins 53:49–58

    Article  PubMed  Google Scholar 

  25. Przylipiak A, Hafner J, Przylipiak J, Koehn FM, Runnebaum B, Rabe T (1998) Influence of 5-lipoxygenase on in vitro growth of human mammary carcinoma cell line MCF-7. Gynecol Obstet Invest 46:61–64

    Article  PubMed  Google Scholar 

  26. Müller-Decker K, Scholz K, Neufang G, Marks F, Fürstenberger G (1998) Localization of prostaglandin-H synthase-1 and -2 in mouse skin: implications for cutaneous function. Exp Cell Res 242:84–91

    Article  PubMed  Google Scholar 

  27. Müller-Decker K, Furstenberger G, Marks F (1994) Keratinocyte-derived proinflammatory key mediators and cell viability as in vitro parameters of irritancy: a possible alternative to the Draize skin irritation test. Toxicol Appl Pharmacol 127:99–108

    Article  PubMed  Google Scholar 

  28. Zouboulis CC, Seltmann H, Hiroi N, Chen W, Young M, Oeff M, Scherbaum WA, Orfanos CE, McCann SM, Bornstein SR (2002) Corticotropin-releasing hormone: an autocrine hormone that promotes lipogenesis in human sebocytes. Proc Natl Acad Sci U S A 99:7148–7153

    Article  PubMed  Google Scholar 

  29. Shappell SB, Keeney DS, Zhang J, Page R, Olson SJ, Brash AR (2001) 15-lipoxygenase-2 expression in benign and neoplastic sebaceous glands and other cutaneous adnexa. J Invest Dermatol 117:36–43

    Article  PubMed  Google Scholar 

  30. Janssen-Timmen U, Vickers P, Wittig U, Lehmann WD, Stark HJ, Fusenig NE, Rosenbach T, Radmark O, Samuelsson B, Habenicht AJR (1995) Expression of 5-lipoxygenase in differentiating human skin keratinocytes. Proc Natl Acad Sci U S A 92:6966–6970

    PubMed  Google Scholar 

  31. Breton J, Woolf D, Young P, Chabot-Fletcher M (1996) Human keratinocytes lack the components to produce leukotriene B4. J Invest Dermatol 106:162–167

    Article  PubMed  Google Scholar 

  32. Kuehn H, Walther M, Kuban RJ (2002) Mammalian arachidonate 15-lipoxygenases. Structure, function, and biological implications. Prostaglandins Other Lipid Mediat 68–69:263–290

    Article  PubMed  Google Scholar 

  33. Boeglin WE, Kim RB, Brash AR (1998) A 12R-lipoxygenase in human skin: mechanistic evidence, molecular cloning, and expression. Proc Natl Acad Sci U S A 95:6744–6749

    Article  PubMed  Google Scholar 

  34. Iversen L, Kragballe K, Ziboh VA (1997) Significance of leukotriene A4 hydrolase in the pathogenesis of psoriasis. Skin Pharmacol 10:169–177

    PubMed  Google Scholar 

  35. Smith KJ, Skelton H (2002) Arachidonic acid-derived bioactive lipids: their role and the role for their inhibitors in dermatology. J Cutan Med Surg 6:241–256

    PubMed  Google Scholar 

  36. Zouboulis CC, Nestoris S, Adler YD, Picardo M, Camera E, Orth M, Orfanos CE, Cunliffe WJ (2003) A new concept for acne therapy: a pilot study with zileuton, an oral 5-lipoxygenase inhibitor. Arch Dermatol 139:668–670

    Article  PubMed  Google Scholar 

  37. Fitzgerald GA (2001) Arachidonic acid is a bioactive molecule. J Clin Invest 107:1339–1345

    PubMed  Google Scholar 

  38. Ziboh VA, Cho Y, Mani I, Xi S (2002) Biological significance of essential fatty acids/prostanoids/lipoxygenase-derived monohydroxy fatty acids in the skin. Arch Pharm Res 25:747–758

    PubMed  Google Scholar 

  39. Laneuville O, Breuer DK, Xu N, Huang ZH, Gage DA, Watson JT, Lagarde M, DeWitt DL, Smith WL (1995) Fatty acid substrate specificities of human prostaglandin-endoperoxide H synthase-1 and -2. Formation of 12-hydroxy-(9Z, 13E/Z, 15Z)-octadecatrienoic acids from alpha-linolenic acid. J Biol Chem 270:19330–19336

    Article  PubMed  Google Scholar 

  40. Anttila HSI, Reitamo S, Saurat J-H (1992) Interleukin 1 immunoreactivity in sebaceous glands. Brit J Dermatol 127:585–588

    Google Scholar 

  41. Boehm KD, Yun JK, Strohl KP, Elmets CA (1995) Messenger RNAs for the multifunctional cytokines interleukin-1α, interleukin-1β and tumor necrosis factor-α are present in adnexal tissues and in dermis of normal human skin. Exp Dermatol 4:335–341

    PubMed  Google Scholar 

  42. Zouboulis CC, Xia L, Akamatsu H, Seltmann H, Fritsch M, Hornemann S, Rühl R, Chen W, Nau H, Orfanos CE (1998) The human sebocyte culture model provides new insights into development and management of seborrhoea and acne. Dermatology 196:21–31

    Article  PubMed  Google Scholar 

  43. Guy R, Green M, Kealey T (1996) Modeling acne in vitro. J Invest Dermatol 106:176–182

    Article  PubMed  Google Scholar 

  44. Zouboulis CC, Saborowski A, Boschnakow A (2005) Zileuton, an oral 5-lipoxygenase inhibitor, directly reduces sebum production. Dermatology 210:36–38

    Article  PubMed  Google Scholar 

  45. Kliewer SA, Sundseth SS, Jones SA, Brown PJ, Wisely GB, Koble CS, Devchand P, Wahli W, Willson TM, Lenhard JM, Lehmann JM (1997) Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. Proc Natl Acad Sci U S A 94:4318–4323

    Article  PubMed  Google Scholar 

  46. Kliewer SA, Lenhard JM, Willson TM, Patel I, Morris DC, Lehmann JM (1995) A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell 83:813–819

    Article  PubMed  Google Scholar 

  47. Forman BM, Tontonoz P, Chen J, Brun RP, Spiegelman BM, Evans RM (1995) 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell 83:803–812

    Article  PubMed  Google Scholar 

  48. Devchand PR, Keller H, Peters JM, Vazquez M, Gonzalez FJ, Wahli W (1996) The PPARα-leukotriene B4 pathway to inflammation control. Nature 336:40–43

    Google Scholar 

  49. Delerive P, De Bosscher K, Besnard S, Vanden Berghe W, Peters JM, Gonzalez FJ, Fruchart JC, Tedgui A, Haegeman G, Staels B (1999) Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1. J Biol Chem 274:32048–32054

    Article  PubMed  Google Scholar 

  50. Gervois P, Vu-Dac N, Kleemann R, Kockx M, Dubois G, Laine B, Kosykh V, Fruchart JC, Kooistra T, Staels B (2001) Negative regulation of human fibrinogen gene expression by peroxisome proliferator-activated receptor alpha agonists via inhibition of CCAAT box/enhancer-binding protein beta. J Biol Chem 276:33471–33477

    PubMed  Google Scholar 

  51. Kleemann R, Gervois PP, Verschuren L, Staels B, Princen HM, Kooistra T (2003) Fibrates down-regulate IL-1-stimulated C-reactive protein gene expression in hepatocytes by reducing nuclear p50-NFkappa B-C/EBP-beta complex formation. Blood 101:545–551

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

Ruta Ganceviciene is a scholarship holder of the Berlin Foundation for Dermatology. We thank the group of Prof. W. Wahli (Center for Integrative Genomics, Lausanne, Switzerland) for the quantification of PPAR mRNA in the sebocyte samples. We are grateful to Dr. S. Pattabhiraman, Mr. H. Seltmann and Mr. A. Hossini for friendly advice and support and to Mrs. E. Glass for excellent technical assistance.

Author information

Authors and Affiliations

  1. Department of Dermatology, Charité Universitaetsmedizin Berlin, Campus Benjamin Franklin, Fabeckstrasse 60-62, 14195, Berlin, Germany

    Theodosios Alestas, Ruta Ganceviciene, Sabine Fimmel & Christos C. Zouboulis

  2. Department of Dermatology, Santariskiu Klinikos, Vilnius University Hospital, Vilnius, Lithuania

    Ruta Ganceviciene

  3. Research Group Eicosanoids and Tumor Development, Deutsches Krebsforschungszentrum, Heidelberg, Germany

    Karin Müller-Decker

  4. Departments of Dermatology and Immunology, Dessau Medical Center, Auenweg 38, 06847, Dessau, Germany

    Christos C. Zouboulis

Authors
  1. Theodosios Alestas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ruta Ganceviciene
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sabine Fimmel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Karin Müller-Decker
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Christos C. Zouboulis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christos C. Zouboulis.

Additional information

T. Alestas and R. Ganceviciene contributed equally to the study

Rights and permissions

Reprints and permissions

About this article

Cite this article

Alestas, T., Ganceviciene, R., Fimmel, S. et al. Enzymes involved in the biosynthesis of leukotriene B4 and prostaglandin E2 are active in sebaceous glands. J Mol Med 84, 75–87 (2006). https://doi.org/10.1007/s00109-005-0715-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00109-005-0715-8

Keywords

Search

Navigation